(Q51558303)

7 April 2018

title

Limitations of glycosylated haemoglobin as an index of glucose intolerance. (English)

1 reference

7 April 2018

0 references

1 reference

Snehalatha C

1

1 reference

7 April 2018

Ramachandran A

series ordinal

2

1 reference

7 April 2018

Satyavani K

series ordinal

3

1 reference

7 April 2018

Vijay V

series ordinal

4

1 reference

7 April 2018

publication date

1 February 2000

1 reference

7 April 2018

Diabetes Research and Clinical Practice

published in

1 reference

7 April 2018

volume

47

1 reference

7 April 2018

issue

2

1 reference

7 April 2018

page(s)

129-133

1 reference

7 April 2018

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

Unexplained variability of glycated haemoglobin in non-diabetic subjects not related to glycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

Significance of High HbA1 Levels in Normal Glucose Tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

Biological variation of glycated hemoglobin. Implications for diabetes screening and monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

How valid is fasting plasma glucose as a parameter of glycemic control in non-insulin-using patients with type 2 diabetes?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

Colorimetric measurement of glycosylated protein in whole blood, red blood cells, plasma and dried blood

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

Combined use of a fasting plasma glucose concentration and HbA1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

Receiver operating characteristic analysis on fasting plasma glucose, HbA1c, and fructosamine on diabetes screening.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

Glycosylation of variant hemoglobins in normal and diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

Interlaboratory variation of GHb assays in Victoria, Australia.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

A clinical approach for the diagnosis of diabetes mellitus: an analysis using glycosylated hemoglobin levels. Meta-analysis Research Group on the Diagnosis of Diabetes Using Glycated Hemoglobin Levels

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8227%2899%2900109-6

7 January 2021

10.1016/S0168-8227(99)00109-6

Identifiers

DOI

1 reference

7 April 2018

PubMed ID

10670913

1 reference

7 April 2018